Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. AMGN - Investing in a Cheap Quarterly Dividend Stock

February 02, 2025
Amgen Inc., a leading biotechnology company, presents an exciting investment opportunity for shareholders. With its strong financial performance and a reputation for delivering innovative treatments, Amgen Inc. has caught the attention of investors. Recently, Cibc World Market Inc. sold its shares in Amgen Inc., leading to increased interest in the company's stock position.

Amgen Inc. has also gained the trust of Exchange Traded Concepts LLC, who has boosted their stock position in the company. This move indicates a positive outlook for Amgen's future growth and solidifies the company's position as an attractive investment.

Wall Street anticipates that Amgen Inc.'s upcoming earnings report will showcase substantial growth. This expectation has further fueled investor confidence in the company. With an average price target of 314.00, Amgen Inc. continues to attract attention from investors worldwide.

In light of these developments, Stocks Prognosis professionals recommend considering the purchase of Amgen Inc. stock. Their expertise in forecasting stock movements can provide valuable insights for making informed investment decisions. Take advantage of this opportunity and consult the professionals at Stocks Prognosis to maximize your investment potential.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

Amgen Inc. has caught my attention with their recent developments. I'm excited about their future prospects and I'll definitely be considering investing in their stock
— from MikeWilliams at 02-05-2025 18:37
I've done my research on Amgen Inc. and I'm confident in their ability to continue growing. Their stock price target is impressive and I believe they are a good choice for investors
— from MoneyMonique at 02-05-2025 14:51
Amgen Inc. is a company that I've been following for a while now. I'm excited to see their stock position improving and I'll definitely consider investing in them
— from TraderTara at 02-05-2025 07:10
I'm skeptical about the hype surrounding Amgen Inc. I need more information about their financials and potential risks before considering investing in their stock
— from CashMike at 02-04-2025 22:42
Amgen Inc. appears to be a strong and reliable investment option. I'm confident in their ability to deliver substantial growth, and I'm excited to see what the future holds for them
— from SavingsSarah at 02-04-2025 15:07
Amgen Inc. has proven themselves as a leading biotechnology company and their strong financial performance speaks for itself. I believe this is a great opportunity for investors to earn a good return
— from MarketMikayla at 02-04-2025 14:06
I'm glad to see Amgen Inc. gaining interest from investors. Their anticipated growth and positive outlook make them a compelling investment option
— from ProfitPiper at 02-03-2025 17:23
I'm impressed with Amgen Inc.'s reputation for delivering innovative treatments. Their stock position looks promising and I'm optimistic about their future growth
— from RiskyRachel at 02-03-2025 17:17
While the news about Amgen Inc. is interesting, I'd prefer to conduct my own analysis before making any investment decisions. I want to have a thorough understanding of the company before investing
— from MadisonReyes at 02-03-2025 05:17
I have faith in Amgen Inc.'s ability to deliver strong financial performance. Their partnerships with reputable companies further solidify their position as a worthwhile investment
— from JessicaMoore at 02-02-2025 23:13
I've heard a lot of positive things about Amgen Inc. recently and it seems like a solid investment opportunity. I'll definitely be keeping an eye on their upcoming earnings report
— from WilliamReed at 02-02-2025 22:52
The professionals at Stocks Prognosis have a solid track record in forecasting stock movements. I trust their recommendation to invest in Amgen Inc. and will seek their expertise
— from AndrewRobinson at 02-02-2025 15:29
I'm not fully convinced about Amgen Inc.'s investment potential. I would like to see more information about their upcoming earnings report and potential risks before making a decision
— from WealthyWendy at 02-02-2025 09:00
This is great news! I've always been impressed with Amgen's innovative treatments and strong financial performance. I'll definitely be looking into investing in their stock
— from AndrewRobinson at 02-02-2025 08:46
If you want to leave a comment, then you need Login or Register





Other news for AMGN

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....



Related news

BIIBFebruary 10, 2025Biogen Inc. BIIB Reports Next Week: Wall Street Expects Earnings Growth  ~1 min.

As Biogen Inc. BIIB prepares to release its quarterly earnings report next week, Wall Street analysts are expecting to see strong growth in the company's earnings....

REGNJanuary 2, 2025Regeneron Pharmaceuticals: An Impressive 89% Return Over the Last Five Years  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been a rewarding investment for shareholders, with a solid 89% return over the past five years, according to Yahoo Finance....

AMGNNovember 24, 2024Amgen Inc. Continues to Lead in Immunotherapy: Experts Recommend Investing in Stocks Prognosis  ~2 min.

Amgen Inc. (NASDAQ: AMGN) has established itself as a frontrunner in immunotherapy research and development, making it a promising investment opportunity for shareholders....

REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....

AMGNFebruary 7, 2025Amgen Inc. AMGN Continues to Impress Hedge Funds and Experts  ~2 min.

Amgen Inc. (NASDAQ:AMGN), one of the leading biotechnology companies, has gained the attention of hedge funds and experts due to its impressive performance....